Volume 22, Issue 3
Pharmacological Agents and Potential New Therapies in Pulmonary Arterial Hypertension
Pp: 155-170
Author(s): Renata Trabach Santos, Maria Eduarda de Sá Freire Onofre, Dayene de Assis Fernandes Caldeira, Adriane Bello Klein, Patricia Rieken Macedo Rocco, Fernanda Ferreira Cruz and Pedro Leme Silva*
DOI: 10.2174/0115701611266576231211045731
Lipoprotein (a) as a Biomarker for Cardiovascular Diseases and Potential New Therapies to Mitigate Risk
Pp: 171-179
Author(s): Debabrata Mukherjee* and Steven E Nissen
DOI: 10.2174/0115701611267835231210054909
Proposal of a Modified Classification of Hypertensive Crises: Urgency, Impending Emergency, and Emergency
Pp: 180-186
Author(s): Goran Koracevic, Milovan Stojanovic*, Marija Zdravkovic, Dragan Lovic, Dragan Simic and Katarina Mladenovic
DOI: 10.2174/0115701611270174231204110557
Effect of Intermittent Fasting on Lipid Profile, Anthropometric and Hepatic Markers in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review
Pp: 187-202
Author(s): María Fernanda Castillo*, Daniela Salgado-Canales, Marco Arrese, Francisco Barrera and Dimitri P Mikhailidis
DOI: 10.2174/0115701611285401240110074530
Dapagliflozin Alleviates Myocardial Ischaemia Reperfusion Injury by Activating Mitophagy via the AMPK-PINK1/Parkin Signalling Pathway
Pp: 203-217
Author(s): Wei Zuo, Liang Wang, Ran Tian, Lun Wang, Yifan Liu, Hao Qian, Xinglin Yang and Zhenyu Liu*
DOI: 10.2174/0115701611269801231211104905
Utilizing Pharmacogenomic Data for a Safer Use of Statins among the Emirati Population
Pp: 218-229
Author(s): Mais N. Alqasrawi, Zeina N. Al-Mahayri, Hiba Alblooshi, Habiba Alsafar and Bassam R. Ali*
DOI: 10.2174/0115701611283841231227064343
